Among small-molecule drugs, upadacitinib and deucravacitinib demonstrate the best efficacy for treatment of psoriatic arthritis, according to data published in Therapeutic Advances in Musculoskeletal ...
More than 125 million people worldwide suffer from some form of psoriasis. If you’ve struggled with your skin health this ...
Managing psoriasis and psoriatic arthritis during the summer involves staying cool, using gentle skin care, and knowing what ...
SECUKINUMAB (SECU) demonstrates sustained effectiveness and high drug survival rates in patients with moderate-to-severe ...
Uncertainty about future care and life impacts were among the top concerns for patients with psoriatic arthritis, but not for ...
A large European study finds that TNF inhibitors work differently across joints in psoriatic arthritis, with the shoulder and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results